| http://dbpedia.org/ontology/abstract
|
Eldelumab (alternative identifier BMS-9365 … Eldelumab (alternative identifier BMS-936557) is a fully human monoclonal antibody (type IgG1 kappa) that targets chemokine (C-X-C motif) ligand 10 (CXCL10)/Interferon-γ-inducible protein-10 (IP-10) designed for the treatment of Crohn's disease and ulcerative colitis. This drug was developed by Bristol-Myers Squibb and Medarex.loped by Bristol-Myers Squibb and Medarex.
, إلديلوماب هو جسم مضاد وحيد النسيلة طورته بريستول مايرز سكويب لعلاج داء كرون والتهاب القولون التقرحي.
|
| http://dbpedia.org/ontology/casNumber
|
946414-98-8
|
| http://dbpedia.org/ontology/fdaUniiCode
|
15O91A27I5
|
| http://dbpedia.org/ontology/kegg
|
D10404
|
| http://dbpedia.org/ontology/wikiPageID
|
38694295
|
| http://dbpedia.org/ontology/wikiPageLength
|
2681
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1092789453
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Crohn%27s_disease +
, http://dbpedia.org/resource/Category:Bristol_Myers_Squibb +
, http://dbpedia.org/resource/Category:Monoclonal_antibodies +
, http://dbpedia.org/resource/Bristol-Myers_Squibb +
, http://dbpedia.org/resource/Monoclonal_antibody +
, http://dbpedia.org/resource/Ulcerative_colitis +
, http://dbpedia.org/resource/CXCL10 +
|
| http://dbpedia.org/property/atcPrefix
|
none
|
| http://dbpedia.org/property/c
|
6502
|
| http://dbpedia.org/property/casNumber
|
946414
|
| http://dbpedia.org/property/chemspiderid
|
none
|
| http://dbpedia.org/property/h
|
10024
|
| http://dbpedia.org/property/kegg
|
D10404
|
| http://dbpedia.org/property/mabType
|
mab
|
| http://dbpedia.org/property/n
|
1736
|
| http://dbpedia.org/property/o
|
2026
|
| http://dbpedia.org/property/s
|
48
|
| http://dbpedia.org/property/source
|
u
|
| http://dbpedia.org/property/target
|
CXCL10/IP-10
|
| http://dbpedia.org/property/type
|
mab
|
| http://dbpedia.org/property/unii
|
15
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:Monoclonal-antibody-stub +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Monoclonals_for_immune_system +
, http://dbpedia.org/resource/Template:Chemokine_receptor_modulators +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Monoclonal_antibodies +
, http://dbpedia.org/resource/Category:Bristol_Myers_Squibb +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Antibody +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Eldelumab?oldid=1092789453&ns=0 +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Eldelumab +
|
| owl:sameAs |
http://yago-knowledge.org/resource/Eldelumab +
, http://fa.dbpedia.org/resource/%D8%A7%D9%84%D8%AF%D9%84%D9%88%D9%85%D8%A7%D8%A8 +
, http://www.wikidata.org/entity/Q10423561 +
, http://rdf.freebase.com/ns/m.0rfcjtl +
, https://global.dbpedia.org/id/7rrK +
, http://ar.dbpedia.org/resource/%D8%A5%D9%84%D8%AF%D9%8A%D9%84%D9%88%D9%85%D8%A7%D8%A8 +
, http://dbpedia.org/resource/Eldelumab +
|
| rdf:type |
http://dbpedia.org/class/yago/MonoclonalAntibody115029781 +
, http://dbpedia.org/class/yago/Part113809207 +
, http://dbpedia.org/class/yago/WikicatMonoclonalAntibodies +
, http://www.wikidata.org/entity/Q8386 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/ontology/Drug +
, http://dbpedia.org/class/yago/Relation100031921 +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/Macromolecule114944888 +
, http://dbpedia.org/class/yago/Matter100020827 +
, http://dbpedia.org/class/yago/Protein114728724 +
, http://dbpedia.org/class/yago/OrganicCompound114727670 +
, http://dbpedia.org/class/yago/Material114580897 +
, http://dbpedia.org/class/yago/Compound114818238 +
, http://dbpedia.org/class/yago/Chemical114806838 +
, http://dbpedia.org/class/yago/Substance100019613 +
, http://dbpedia.org/ontology/MonoclonalAntibody +
, http://dbpedia.org/class/yago/Thing100002452 +
, http://dbpedia.org/class/yago/Molecule114682133 +
, http://dbpedia.org/class/yago/Unit109465459 +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://dbpedia.org/class/yago/PhysicalEntity100001930 +
, http://dbpedia.org/class/yago/Antibody115027189 +
|
| rdfs:comment |
إلديلوماب هو جسم مضاد وحيد النسيلة طورته بريستول مايرز سكويب لعلاج داء كرون والتهاب القولون التقرحي.
, Eldelumab (alternative identifier BMS-9365 … Eldelumab (alternative identifier BMS-936557) is a fully human monoclonal antibody (type IgG1 kappa) that targets chemokine (C-X-C motif) ligand 10 (CXCL10)/Interferon-γ-inducible protein-10 (IP-10) designed for the treatment of Crohn's disease and ulcerative colitis. This drug was developed by Bristol-Myers Squibb and Medarex.loped by Bristol-Myers Squibb and Medarex.
|
| rdfs:label |
إلديلوماب
, Eldelumab
|
